Fund Sells $11M Cavco Stock: Rebalancing or Warning?

On February 13, 2026, Ashford Capital Management disclosed selling 19,607 shares of Cavco Industries (CVCO) worth approximately $11.11 million. This represented a significant reduction in their position, leaving them with 28,412 shares valued at $16.78 million at quarter-end.

The sale occurred during the fourth quarter of 2025, with the transaction value calculated using the quarter's average pricing. The net position change, accounting for both trades and stock price movements, totaled $11.10 million.

Following this transaction, Cavco's weighting in Ashford's portfolio dropped from 3.1% to just 1.87% of their reportable assets. This suggests the fund was actively rebalancing its exposure rather than making a minor adjustment.

The timing is interesting given Cavco's stock performance - shares were trading at $590.38 on February 13, having gained 10.3% over the past year but still underperforming the S&P 500 by 1.5 percentage points.

Institutional sales of this magnitude often trigger investor concern, but context matters greatly. Ashford's move appears to be strategic portfolio management rather than a vote against Cavco's business fundamentals.

The fund's portfolio composition provides important clues. With higher-beta names like Globalstar (6.8% of AUM) and Ligand (4.5%) as top holdings, Cavco's more stable profile might have been reduced to rebalance risk exposure. This is common practice among professional money managers.

Cavco's underlying business remains healthy. The company reported 11.3% year-over-year revenue growth in its latest quarter, driven by higher home sales volume and pricing. Their $160 million backlog represents 4-6 weeks of production, indicating sustained demand.

For retail investors, the key takeaway is that not all institutional selling signals trouble. Sometimes it's simply about portfolio construction and risk management, especially when a stock has performed well and a fund needs to rebalance its allocations.